Affymax, (FRA:A5Y) Other Long Term Assets : €0.69 Mil (As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is Affymax, Other Long Term Assets?

Affymax,'s other long-term assets for the quarter that ended in Jun. 2014 was €0.69 Mil.

Affymax,'s quarterly other long-term assets declined from Dec. 2013 (€0.82 Mil) to Mar. 2014 (€0.73 Mil) but then stayed the same from Mar. 2014 (€0.73 Mil) to Jun. 2014 (€0.69 Mil).

Affymax,'s annual other long-term assets increased from Dec. 2011 (€6.36 Mil) to Dec. 2012 (€7.93 Mil) but then declined from Dec. 2012 (€7.93 Mil) to Dec. 2013 (€0.82 Mil).

Affymax, Other Long Term Assets Historical Data

The historical data trend for Affymax,'s Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Other Long Term Assets Chart

Affymax, Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Other Long Term Assets

Get a 7-Day Free Trial

5.02

6.04

6.36

7.93

0.82

Affymax, Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Other Long Term Assets	Get a 7-Day Free Trial															7.17	6.06	0.82	0.73	0.69

Affymax, Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Affymax, (FRA:A5Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020

Website

http://www.affymax.com

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines